Kitelock 4%

Register an interest in this topic

Topic Status Incomplete

Kitelock 4% in the prevention of central line catheter associated bloodstream infection and blood clots

Summary

 

Health Technology Wales researchers searched for evidence on the use of Kitelock 4% to prevent central line catheter associated bloodstream infection and blood clots.

Based on the evidence identified, HTW’s Assessment Group concluded to progress this topic to Evidence Appraisal.

Topic Exploration Report

TER486 02.2024

Our advice documents are free to download but we would be grateful if you could help us improve our services by telling us why you are looking at our advice.

Skip form and download file Close

    We may like to contact you by email to find out more about how you used the documents.